Pharma major Wockhardt has said that it has received approval from the US drug regulator for marketing its antiepileptic tablet Levetiracentam in that country. The company has received approval from the United States Food & Drug Administration (USFDA) for marketing of Levetiracentam tablets in the strength of 250, 500, 750 mg and 1 gm, Wockhardt said in a filing to the Bombay Stock Exchange. Levetiracentam tablets are used in the treatment of various kinds of epileptic seizures.
The Public Gambling Act, 1867 also known as the "Gambling Act" is the primary law which governs gambling in India. However, the state legislatures, under the Constitution of India, are currentl More
Helplinelaw can set up your session with quality and experienced lawyers to discuss and resolve your legal matters. You can avail consultation in form of sending questions, phone call or webchat discussion More